TCWP’s Bristol-Myers Squibb BMY Stock Holding History

TCWP’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,891	Closed	-$922K	–	60
2023 Q3	$922K	Sell	15,891 -73,484	-82%	-$4.5M	0.7%	44
2023 Q2	$5.72M	Buy	89,375 +70,925	+384%	+$4.76M	1.22%	26
2023 Q1	$1.28M	Buy	18,450 +11,919	+182%	+$841K	0.24%	90
2022 Q4	$469K	Sell	6,531 -1,477	-18%	-$111K	0.1%	148
2022 Q3	$569K	Buy	8,008 +247	+3%	+$17.9K	0.12%	130
2022 Q2	$597K	Buy	7,761 +1,172	+18%	+$89.3K	0.13%	124
2022 Q1	$481K	Sell	6,589 -73,398	-92%	-$4.93M	0.09%	151
2021 Q4	$4.99M	Buy	+79,987	New	+$4.69M	0.99%	22

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TCWP's BMY Position: Q4 2023 in Review

TCWP sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 15,891 shares — an estimated $922K sold.

TCWP first reported a position in BMY in Q4 2021 and held it in 8 quarters. The position peaked at $5.72M in Q2 2023. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

TCWP reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
TCWP sold 15,891 Bristol-Myers Squibb shares in Q4 2023, an estimated $922K.
TCWP first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 8 quarters.
TCWP's Bristol-Myers Squibb position peaked at $5.72M in Q2 2023.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on TCWP's 13F filing for Q4 2023, filed 14 Feb 2024.